[Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units]
- PMID: 24713089
- DOI: 10.1016/j.medin.2014.02.004
[Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units]
Abstract
The presence of respiratory fungal infection in the critically ill patient is associated with high morbidity and mortality.
Objectives: To assess the incidence of respiratory infection caused by Aspergillus spp. independently of the origin of infection in patients admitted to Spanish ICUs, as well as to describe the rates, characteristics, outcomes and prognostic factors in patients with this type of infection.
Material and methods: An observational, retrospective, open-label and multicenter study was carried out in a cohort of patients with respiratory infection caused by Aspergillus spp. admitted to Spanish ICUs between 2006 and 2012 (months of April, May and June), and included in the ENVIN-HELICS registry (108,244 patients and 825,797 days of ICU stay). Variables independently related to in-hospital mortality were identified by multiple logistic regression analysis.
Results: A total of 267 patients from 79 of the 198 participating ICUs were included (2.46 cases per 1000 ICU patients and 3.23 episodes per 10,000 days of ICU stay). From a clinical point of view, infections were classified as ventilator-associated pneumonia in 93 cases (34.8%), pneumonia unrelated to mechanical ventilation in 120 cases (44.9%), and tracheobronchitis in 54 cases (20.2%). The study population included older patients (mean 64.8±17.1 years), with a high severity level (APACHE II score 22.03±7.7), clinical diseases (64.8%) and prolonged hospital stay before the identification of Aspergillus spp. (median 11 days), transferred to the ICU mainly from hospital wards (58.1%) and with high ICU (57.3%) and hospital (59.6%) mortality rates, exhibiting important differences depending on the type of infection involved. Independent mortality risk factors were previous admission to a hospital ward (OR=7.08, 95%CI: 3.18-15.76), a history of immunosuppression (OR=2.52, 95%CI: 1.24-5.13) and severe sepsis or septic shock (OR=8.91, 95%CI: 4.24-18.76).
Conclusions: Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the ICU in Spain are infrequent, and affect a very selected group of patients, characterized by high mortality and conditioned by non-modifiable risk factors.
Keywords: Aspergillus spp.; Aspergillus spp., Critically ill patientl; Fungal respiratory infection; Infección respiratoria por hongos; Intensive care unit; Mortalidad; Mortality; Paciente crítico; Unidad de cuidados intensivos.
Copyright © 2013 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.
Similar articles
-
Characteristics and outcomes of patients admitted to Spanish ICU: A prospective observational study from the ENVIN-HELICS registry (2006-2011).Med Intensiva. 2016 May;40(4):216-29. doi: 10.1016/j.medin.2015.07.003. Epub 2015 Oct 9. Med Intensiva. 2016. PMID: 26456793 English, Spanish.
-
Epidemiological study of Clostridium difficile infection in critical patients admitted to the Intensive Care Unit.Med Intensiva. 2014 Dec;38(9):558-66. doi: 10.1016/j.medin.2013.11.007. Epub 2014 Feb 3. Med Intensiva. 2014. PMID: 24503331 English, Spanish.
-
[Patients treated with micafungin during their stay in intensive care unit].Med Intensiva. 2015 Nov;39(8):467-76. doi: 10.1016/j.medin.2014.10.010. Epub 2015 Mar 20. Med Intensiva. 2015. PMID: 25798955 Spanish.
-
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.Rev Esp Quimioter. 2013 Jun;26(2):173-88. Rev Esp Quimioter. 2013. PMID: 23817660 Review.
-
ICU-acquired infections in immunocompromised patients.Intensive Care Med. 2024 Mar;50(3):332-349. doi: 10.1007/s00134-023-07295-2. Epub 2024 Jan 10. Intensive Care Med. 2024. PMID: 38197931 Review.
Cited by
-
Galactomannan Downregulates the Inflammation Responses in Human Macrophages via NFκB2/p100.Mediators Inflamm. 2015;2015:942517. doi: 10.1155/2015/942517. Epub 2015 Sep 9. Mediators Inflamm. 2015. PMID: 26441484 Free PMC article.
-
Pseudomembranous Aspergillus tracheobronchitis: A Rare Manifestation of Invasive Aspergillosis in a Immunocompetent Patient.Infect Drug Resist. 2025 Mar 5;18:1297-1302. doi: 10.2147/IDR.S495620. eCollection 2025. Infect Drug Resist. 2025. PMID: 40059942 Free PMC article.
-
Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan.PLoS One. 2017 Oct 19;12(10):e0186422. doi: 10.1371/journal.pone.0186422. eCollection 2017. PLoS One. 2017. PMID: 29049319 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous